Gambaran Keberhasilan Pengobatan (Treatment Success Rate) Tuberkulosis Paru di Puskesmas Jatisampurna, Bekasi
Description of Treatment Success Rate for Pulmonary Tuberculosis at Jatisampurna Community Health Center, Bekasi
Abstract
Latar belakang: Tuberkulosis Paru merupakan penyakit radang paru yang diperkirakan menginfeksi sepertiga penduduk di dunia, dengan gejala utama yaitu batuk produktif, demam, keringat malam, penurunan berat badan.
Tujuan: Penelitian ini bertujuan untuk menggambarkan capaian keberhasilan pengobatan Tuberkulosis Paru.
Metode: Metode analisis menggunakan deskrptif statistic dengan menggunakan data sekunder. sampel data berjumlah 77 pasien TB Paru di Puskesmas Jatisampurna yang dipilih menggunakan teknik consecutive sampling. Analisis menggunakan statistik deskriptif tentang karakteristik jenis kelamin, pekerjaan, usia, status pengobatan, pemeriksaan kontak, status rujukan, tipe diagnosis, riwayat pengobatan, paduan OAT, klasifikasi anatomi, riwayat penyakit, dan pemeriksaan hasil pengobatan.
Hasil: Hasil didapatkan bahwa pasien TB Paru yang dinyatakan sembuh hanya sebesar 16.9% dan didominasi dengan status tidak diketahui sebesar 49.4%. Tidak tercapaianya target tersebut dikarenakan adanya faktor tidak dilakukannya pemeriksaan kontak, riwayat pengobatan yang tidak diketahui, dan pasien hanya aktif saat melakukan pemeriksaan pra pengobatan, sedangkan untuk pemeriksaan selanjutnya pasien tidak diketahui statusnya.
Kesimpulan: Capaian keberhasilan pengobatan TB Paru di Puskesmas Jatisampurna yang disebabkan oleh faktor pemeriksana kontak, riwayat pengobatan, dan keaktifan pasien melakukan pemeriksaan.
References
Heemskerk D, Caws M, Marais B, Farrar J. Tuberculosis in adults and children. 2015;
Fitriana F, Anis W, Mukarromah L, Aenah W. Modul Tuberkulosis Paru Pada Kehamilan Untuk Kader Kesehatan. Airlangga University Press; 2021.
Lewis SL, Bucher L, Heitkemper MM, Harding MM, Kwong J, Roberts D. Medical-Surgical Nursing-E-Book: Assessment and Management of Clinical Problems, Single Volume. Elsevier Health Sciences; 2016.
MacNeil A, Glaziou P, Sismanidis C, Date A, Maloney S, Floyd K. Global epidemiology of tuberculosis and progress toward meeting global targets—worldwide, 2018. Morbidity and Mortality Weekly Report. 2020;69(11):281.
Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, et al. Global Tuberculosis Report 2020–Reflections on the Global TB burden, treatment and prevention efforts. International journal of infectious diseases. 2021;113:S7–12.
WHO. World Health Organization Global Tuberculosis Report 2021. URL: https://www who int/teams/global-tuberculosis-programme/tbreports/global-tuberculosis-report-2021. 2021;
Riskesdas K. Hasil utama riset kesehata dasar (RISKESDAS). Journal of Physics A: Mathematical and Theoretical. 2018;44(8):1–200.
Kemenkes R. Rencana Strategis Kementrian Kesehatan Tahun 2020-2024. Jakarta: Kementrian Hukum dan Hak Asasi Manusia. 2020;
Ulfah U, Windiyaningsih C, Abidin Z, Murtiani F. Faktor-Faktor yang berhubungan dengan kepatuhan berobat pada penderita tuberkulosis paru. The Indonesian Journal of Infectious Diseases. 2018;4(1).
Supriatun E, Insani U. Pencegahan Tuberkulosis. Lembaga Chakra Brahmana Lentera; 2020.
Utami STP. Gambaran Pelaksanaan Program Tuberkulosis Di Puskesmas Kebon Handil Kota Jambi Tahun 2022. Electronic Journal Scientific of Environmental Health And Disease. 2022;3(2):122–30.
Setyanur FR, Sunarto S. Pelayanan dan Keberhasilan Pengobatan pada Pasien Tuberkulosis di Puskesmas Bandongan Magelang. In: Jurnal Formil (Forum Ilmiah) Kesmas Respati. 2023. p. 292–304.
CDC. TB Treatment and Case Outcomes [Internet]. 2021. Available from: https://www.cdc.gov/tb/statistics/reports/2021/outcomes.htm
Kemenkes R. Peraturan Menteri Kesehatan Republik Indonesia nomor 67 tahun 2016 tentang penanggulangan tuberkulosis. Jakarta: Kementerian Kesehatan Republik Indonesia. 2016;
Allen M. Secondary Data. In: The SAGE Encyclopedia of Communication Research Methods. SAGE Publications, Inc; 2017.
Ackerman B, Schmid I, Rudolph KE, Seamans MJ, Susukida R, Mojtabai R, et al. Implementing statistical methods for generalizing randomized trial findings to a target population. Addictive Behaviors. 2019 Jul 1;94:124–32.
Bayot ML, Mirza TM, Sandeep ;, Affiliations S. Acid Fast Bacteria [Internet]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537121/?report=printable
Riello FN, Brígido RTS, Araújo S, Moreira TA, Goulart LR, Goulart IMB. Diagnosis of mycobacterial infections based on acid-fast bacilli test and bacterial growth time and implications on treatment and disease outcome. BMC Infect Dis. 2016;16(1).
Prada-Ramallal G, Takkouche B, Figueiras A. Bias in pharmacoepidemiologic studies using secondary health care databases: A scoping review. Vol. 19, BMC Medical Research Methodology. BioMed Central Ltd.; 2019.
Rostam S, Kalhori N, Nasehi M, Zeng XJ. A Logistic Regression Model to Predict High Risk Patients to Fail in Tuberculosis Treatment Course Completion. In: IAENG International Journal of Applied Mathematics [Internet]. 2018. Available from: https://www.researchgate.net/publication/43807889
Soedarsono S, Mertaniasih NM, Kusmiati T, Permatasari A, Juliasih NN, Hadi C, et al. Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects. BMC Pulm Med. 2021 Dec 1;21(1).
WHO. Global Tuberculosis Report 2021 [Internet]. [cited 2023 Oct 23]. Available from: https://www.who.int/publications/i/item/9789240037021
Wu Q, Wang M, Zhang Y, Wang W, Ye TF, Liu K, et al. Epidemiological Characteristics and Their Influencing Factors Among Pulmonary Tuberculosis Patients With and Without Diabetes Mellitus: A Survey Study From Drug Resistance Surveillance in East China. Front Public Health. 2022 Jan 24;9.
Fang XH, Dan YL, Liu J, Jun L, Zhang ZP, Kan XH, et al. Factors influencing completion of treatment among pulmonary tuberculosis patients. Patient Prefer Adherence. 2019;13:491–6.
Guo J, Liu Z Da, Feng YP, Luo SR, Jiang QM. Assessment of Effective Anti-TB Regimens and Adverse Outcomes Related Risk Factors in the Elderly and Senile-Aged TB Patients. Infect Drug Resist. 2023;16:3903–15.
Fox GJ, Dobler CC, Marks GB. Active case finding in contacts of people with tuberculosis. Cochrane Database of Systematic Reviews. 2011 Sep 7;
Du Y, He Y, Zhang H, Shen F, Guan L, Xin H, et al. Declining incidence rate of tuberculosis among close contacts in five years post-exposure: a systematic review and meta-analysis. BMC Infect Dis. 2023 Dec 1;23(1).
Reichler MR, Khan A, Sterling TR, Zhao H, Moran J, McAuley J, et al. Risk and timing of tuberculosis among close contacts of persons with infectious tuberculosis. Journal of Infectious Diseases. 2018 Aug 14;218(6):1000–8.
Nair D, Rajshekhar N, Klinton JS, Watson B, Velayutham B, Tripathy JP, et al. Household contact screening and yield of tuberculosis cases-a clinic based study in Chennai, South India. PLoS One. 2016 Sep 1;11(9).
Chen C, Zhu L, Yang D, Shao Y, Song H, Li S, et al. Risk factors associated with TB, a case-control study in a Chinese population. J Public Health Emerg. 2017 Jun 13;1:58–58.
Authors who publish with Journal of Public Health and Pharmacy retain the copyright of their work. The journal applies a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), which grants the following rights:
-
Copyright Retention: Authors retain the copyright of their work, maintaining full control over their intellectual property without restrictions.
-
Right of First Publication: Authors grant the journal the right of first publication of their work. This ensures that the work is initially published and credited in Journal of Public Health and Pharmacy.
-
License to Share and Reuse: The work is licensed under CC BY-SA 4.0, allowing others to copy, distribute, remix, and build upon the work for any purpose, even commercially, as long as proper credit is given to the authors, and any new creations are licensed under the same terms.
